Submitted by Anonymous (not verified) on 10 November 2026 - 14:22
Human medicines European public assessment report (EPAR): Tenkasi (previously Orbactiv), oritavancin, Date of authorisation: 19/03/2015, Revision: 18, Status: Authorised
Source: